You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Epidermal growth factor receptor wild type

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)

Recruiting
  • HR+/HER2- Advanced Breast Cancer
  • Targeted Therapy
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Aug 1, 2023

Metastatic Colorectal Cancer Trial in Beijing, Tianjin (CMAB009, Irinotecan, Folinic acid)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Beijing, Beijing, China
  • +1 more
Oct 18, 2022

Circulating Tumour DNA Testing in Assessing for Alterations of

Recruiting
  • Colorectal Cancer
    • Singapore, Singapore
      National University Hospital
    Sep 28, 2021

    Metastatic Colorectal Cancer Trial in Australia (Sodium Valproate, Panitumumab, Cetuximab)

    Recruiting
    • Metastatic Colorectal Cancer
    • Sodium Valproate
    • +2 more
    • Saint Leonards, New South Wales, Australia
    • +8 more
    Jan 22, 2023

    Recurrent Glioblastoma Trial (Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T

    Not yet recruiting
    • Recurrent Glioblastoma
    • Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T cell injection
    • (no location specified)
    Apr 4, 2023

    Advanced Colorectal Cancer Trial in Seoul (Cetuximab, irinotecan)

    Completed
    • Advanced Colorectal Cancer
    • Cetuximab, irinotecan
    • Seoul, Korea, Republic of
      Asan Medical Center
    Jan 17, 2021

    Colo-rectal Cancer Trial (biological, drug, procedure)

    Not yet recruiting
    • Colo-rectal Cancer
    • Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
    • +8 more
    • (no location specified)
    Aug 28, 2023

    NSCLC (NSCLC) Trial (Osimertinib, Amivantamab)

    Not yet recruiting
    • Non-Small Cell Lung Cancer (NSCLC)
    • (no location specified)
    Mar 24, 2023

    Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations Trial in

    Recruiting
    • Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations
    • Canton, Ohio
      Gabrail Cancer and Research Center
    Jul 21, 2023

    Breast Cancer Trial in Sarasota, Nashville (AC699)

    Recruiting
    • Breast Cancer
    • Sarasota, Florida
    • +1 more
    Jan 3, 2023

    Breast Cancer Invasive Trial (pyrotinib)

    Not yet recruiting
    • Breast Cancer Invasive
    • (no location specified)
    Jun 18, 2023

    OPTImal PALliative Anti-epidermal Growth Factor Receptor

    Active, not recruiting
    • Colorectal Cancer Metastatic
    • +5 more
    • Plasma circulating DNA analysis
    • Aarhus, Denmark
      Aarhus University Hospital
    Feb 24, 2022

    Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

    Recruiting
    • Hormone Receptor Positive HER-2 Negative Breast Cancer
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Jun 12, 2023

    Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Ocala (Samuraciclib, Fulvestrant)

    Recruiting
    • Metastatic Breast Cancer
    • +2 more
    • Ocala, Florida
      Ocala Oncology Center PL DBA Florida Cancer Affiliates
    Jul 19, 2023

    Breast Cancer Trial in Beijing, Zhengzhou, Changsha (EG017)

    Not yet recruiting
    • Breast Cancer
    • Beijing, Benjing, China
    • +2 more
    Dec 30, 2022

    Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation Trial in Canton (TAS6417)

    Recruiting
    • Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
    • Canton, Ohio
      Gabrail Cancer and Research Center
    Jul 25, 2023

    Brain Metastases, Human Epidermal Growth Factor 2 Positive Carcinoma of Breast, Advanced Breast Cancer Trial (Trastuzumab,

    Recruiting
    • Brain Metastases
    • +2 more
    • Saint Louis, Missouri
    • +1 more
    Nov 8, 2022

    Non Small Cell Lung Cancer Trial in Durham (Atezolizumab, Bevacizumab)

    Active, not recruiting
    • Non Small Cell Lung Cancer
    • Durham, North Carolina
      Duke University Medical Center
    May 23, 2022

    Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia Trial (HT-001 2% Topical Gel, HT-001 1% Topical Gel, HT-001 0.5%

    Not yet recruiting
    • Acneiform Eruption Due to Chemical
    • +2 more
    • HT-001 2% Topical Gel
    • +3 more
    • (no location specified)
    Dec 3, 2022

    Locally Advanced or Unresectable Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Marietta, East Brunswick (Sacituzumab

    Recruiting
    • Locally Advanced or Unresectable Metastatic Breast Cancer
    • Stage IV Breast Cancer
    • Sacituzumab Govitecan-hziy
    • +3 more
    • Marietta, Georgia
    • +1 more
    Apr 21, 2023

    Breast Cancer Trial (Tucatinib, Doxil)

    Not yet recruiting
    • Breast Cancer
    • (no location specified)
    Feb 17, 2023

    Breast Cancer, Breast Cancer, Early-Onset Trial (Giredestrant, Tamoxifen)

    Not yet recruiting
    • Breast Cancer
    • Breast Cancer, Early-Onset
    • (no location specified)
    Jan 18, 2023

    EGFR Mutation-Related Tumors Trial (NX-019)

    Not yet recruiting
    • EGFR Mutation-Related Tumors
    • (no location specified)
    Aug 22, 2022

    RAS Wild-type mCRC Resistance to Anti-EGFR-antibody

    Completed
    • Colorectal Cancer
      • Guanzhou, Guangdong, China
        Medical Oncology,Sun Yat-sen University Cancer Center
      Jul 6, 2020

      NSCLC Trial (Amivantamab, Lazertinib, Doxycycline)

      Not yet recruiting
      • Carcinoma, Non-Small-Cell Lung
      • (no location specified)
      Nov 7, 2023